Wiley

PROTEOMICS - CLINICAL APPLICATIONS Template

Write in a clean editor, then format for PROTEOMICS - CLINICAL APPLICATIONS in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the PROTEOMICS - CLINICAL APPLICATIONS format

PROTEOMICS - CLINICAL APPLICATIONS is a peer-reviewed journal published by Wiley, covering Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications, Advanced Biosensing Techniques and Applications.

PublisherWiley
Reference styleAuthor–year (Chicago)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." PROTEOMICS - CLINICAL APPLICATIONS 12 (3): 45–58.

Formats any DOI in PROTEOMICS - CLINICAL APPLICATIONS style. No sign-up.

Publishes research inAdvanced Proteomics Techniques and Applications Mass Spectrometry Techniques and Applications Advanced Biosensing Techniques and Applications Biotin and Related Studies Glycosylation and Glycoproteins Research
ISSN1862-8346
Citation impact (2-yr)2.23
h-index76
i10-index1,013
Total citations40,294
Article processing charge$4,020
Top institutions publishing hereJohns Hopkins University
Journal websiteonlinelibrary.wiley.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in PROTEOMICS - CLINICAL APPLICATIONS per year

149
2014
146
2015
148
2016
118
2017
136
2018
94
2019
66
2020
67
2021
60
2022
56
2023
68
2024
52
2025

Citation impact of PROTEOMICS - CLINICAL APPLICATIONS by publication year

4.3K
2014
4.3K
2015
2.3K
2016
1.7K
2017
2.4K
2018
1.2K
2019
772
2020
394
2021
407
2022
353
2023
232
2024
46
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in PROTEOMICS - CLINICAL APPLICATIONS

Exosomes in bodily fluids are a highly stable resource of disease biomarkers

Stephanie Boukouris, Suresh Mathivanan · 13 Feb 2015

Biomarkers are measurable indicators of a biological state. As our understanding of diseases meliorates, it is generally accepted that early diagnosis renders the best chance to cure a disease. In the context of proteomics, the discovery phase of identifying bonafide biomarkers and the ensuing validation phase involving large cohort of patient samples are impeded by…

Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons?

Eva‐Maria Krämer‐Albers, Niko P. Bretz, Stefan Tenzer et al. · 16 Oct 2007

Oligodendrocytes synthesize the CNS myelin sheath by enwrapping axonal segments with elongations of their plasma membrane. Spatial and temporal control of membrane traffic is a prerequisite for proper myelin formation. The major myelin proteolipid protein (PLP) accumulates in late endosomal storage compartments and multivesicular bodies (MVBs). Fusion of MVBs with the plasma membrane results in…

Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy

Elizabeth Hamson, Fiona M. Keane, Stefan Tholen et al. · 28 Jan 2014

Fibroblast activation protein (FAP) is best known for its heightened expression in tumour stroma. This atypical serine protease has both dipeptidyl peptidase and endopeptidase activities, cleaving substrates at a post-proline bond. FAP expression is difficult to detect in non-diseased adult organs, but is greatly upregulated in sites of tissue remodelling, which include liver fibrosis, lung…

ELISA in the multiplex era: Potentials and pitfalls

Patrick J. Tighe, Richard R. Ryder, Ian Todd et al. · 23 Jan 2015

Multiplex immunoassays confer several advantages over widely adopted singleplex immunoassays including increased efficiency at a reduced expense, greater output per sample volume ratios and higher throughput predicating more resolute, detailed diagnostics and facilitating personalised medicine. Nonetheless, to date, relatively few protein multiplex immunoassays have been validated for in vitro diagnostics in clinical/point-of-care settings. This review…

Trans‐Proteomic Pipeline, a standardized data processing pipeline for large‐scale reproducible proteomics informatics

Eric W. Deutsch, Luis Mendoza, David Shteynberg et al. · 29 Jan 2015

Democratization of genomics technologies has enabled the rapid determination of genotypes. More recently the democratization of comprehensive proteomics technologies is enabling the determination of the cellular phenotype and the molecular events that define its dynamic state. Core proteomic technologies include MS to define protein sequence, protein:protein interactions, and protein PTMs. Key enabling technologies for proteomics…

PROTEOMICS - CLINICAL APPLICATIONS template — frequently asked questions

How do I write a paper in the PROTEOMICS - CLINICAL APPLICATIONS format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the PROTEOMICS - CLINICAL APPLICATIONS template. When you export, DocuGuru compiles the paper into the official Wiley format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does PROTEOMICS - CLINICAL APPLICATIONS use?
PROTEOMICS - CLINICAL APPLICATIONS uses Author–year (Chicago) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." PROTEOMICS - CLINICAL APPLICATIONS 12 (3): 45–58.
Do I need to know LaTeX to submit to PROTEOMICS - CLINICAL APPLICATIONS?
No. DocuGuru generates the USG LaTeX class and compiles the PDF for you in the background, so you get a Wiley-ready PROTEOMICS - CLINICAL APPLICATIONS document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the PROTEOMICS - CLINICAL APPLICATIONS template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the PROTEOMICS - CLINICAL APPLICATIONS format with correct headings, figures, tables, and author–year citations.
Who publishes PROTEOMICS - CLINICAL APPLICATIONS?
PROTEOMICS - CLINICAL APPLICATIONS is a multidisciplinary journal published by Wiley. DocuGuru's PROTEOMICS - CLINICAL APPLICATIONS template matches Wiley's official submission format.
Can I export a submission-ready PROTEOMICS - CLINICAL APPLICATIONS PDF?
Yes — DocuGuru produces a PDF built with the official PROTEOMICS - CLINICAL APPLICATIONS template (the USG class) that is ready to submit to Wiley, together with the matching LaTeX source files.
How much does the PROTEOMICS - CLINICAL APPLICATIONS template cost?
You can start writing in the PROTEOMICS - CLINICAL APPLICATIONS template for free. Exporting the final submission-ready PROTEOMICS - CLINICAL APPLICATIONS PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the PROTEOMICS - CLINICAL APPLICATIONS template